Emyria
Emyria is a drug development and clinical care company focused on novel treatments for mental health and neurological conditions.
About
Technology stack
detected 2026-06-18No comments yet. Be the first to share your take.
What does Emyria do?
Emyria is an ASX-listed, data-backed drug development and care delivery company focused on unmet needs in mental health and neurological conditions. They combine frontline care with clinical research and real-world data to develop new therapies and breakthrough treatments, including psychedelic-assisted therapies and cannabinoid-based medicines. Emyria operates a network of specialist medical clinics and uses proprietary clinical evidence to accelerate drug development and registration.
Where is Emyria headquartered?
Emyria is headquartered in Perth, Australia.
When was Emyria founded?
Emyria was founded in 2019.
What industry does Emyria operate in?
Emyria operates in HealthTech, Biotech, Drug Discovery, Clinical Trials, Mental Health Tech, Psychedelic-Assisted Therapy.